Nicergoline in the treatment of mild-to-moderate Alzheimer's disease: A European multicentre trial

Clinical Drug Investigation

Volumn 21, Issue 9, 2001, Pages 621-632

  Winblad, B ^a   Bonura, M L ^b   Rossini, B M ^c   Battaglia, A ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b PFIZER INC   (United States)

^c Market Company Italy   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NICERGOLINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

EID: 0034779562     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200121090-00004     Document Type: Article

References (26)

1. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
2. Cholinergic markers in elderly patients with early signs of Alzheimer's disease
3. Alzheimer's disease: More than a 'cholinergic disorder' - Evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia
4. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia
5. Nicergoline in dementia
6. Clinical diagnosis of Alzheimer's disease: Report on the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
7. Mini-mental state: A practical method for grading the cognitive state of patients for the physician
8. Development of a rating scale for primary depressive illness
9. A new rating scale for Alzheimer's disease
10. Validity and reliability of the Alzheimer's Disease Cooperative Study - Clinical global impression of change
11. Assessment of older people: Self maintaining and instrumental activities of daily living
12. Scales to measure competence in everyday activities
13. A 30 week randomized controlled trial of high dose tactine in patients with Alzheimer's disease
14. Tacrine in patients with Alzheimer's disease: A double-blind, placebo-controlled multicenter study
15. A 12-week, double-blind, placebo-controlled, parallel-group study of tactine in patients with probable Alzheimer's disease
16. Cardinal features of cognitive dysfunction in Alzheimer's disease: A factor analytic study of the Alzheimer's Disease Assessment Scale
17. A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia
18. Long-term nicergoline treatment of mild to moderate senile dementia
19. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: A double-blind, placebo-controlled, clinical and EEG/ERP mapping study
20. Mental and behavioural disturbances in dementia: Finding from the Cache County study on memory in aging
21. Treating behavioural and psychological signs in AD
22. Integrated analysis of safety data from double blind, placebo-controlled clinical trials in mild to moderate dementia